Médicos de Imunoterapia no exterior — Página 3

O Professor Associado Tahsin Ozatli é especializado em cânceres de mama, pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Mais de uma década de experiência em oncologia
• Trabalhou na Clínica de Oncologia de Ancara e no Hospital Regional de Treinamento e Pesquisa de Erzurum
• Promovido a Professor Associado em 2016
• Estudou medicina na Universidade Selcuk

Professor Associado de Oncologia Médica na İstinye University Liv Hospital Topkapı – especialista em imunoterapia para o tratamento do câncer.

• Mais de 10 anos de experiência em oncologia médica
• Membro da American Society of Clinical Oncology (ASCO)
• Publicou múltiplos artigos revisados por pares sobre os resultados do tratamento oncológico
• Foca-se na imunoterapia para vários tipos de câncer

O Prof. Assoc. Nail Paksoy é especializado em imunoterapia no Hospital Medipol Bahçelievler, com uma forte experiência em oncologia médica e alergia-imunologia.

• Certificado pela ESMO em Oncologia Médica
• Participou em 8 ensaios clínicos internacionais para imunoterapia
• Publicou vários estudos sobre resultados de tratamento de câncer
• Formação de Fellowship no Instituto de Oncologia da Universidade de Istambul

O Dr. Salman é especialista em imunoterapia para vários tipos de câncer, integrando terapias direcionadas e vacinas contra o câncer. Ele realizou sua formação em instituições de prestígio, como o Memorial Sloan Kettering Cancer Center.

• Professor Associado na Universidade Katip Çelebi com mais de 7 anos em oncologia médica
• Visitante acadêmico no Moffitt Cancer Center na Flórida, EUA
• Membro do conselho da Sociedade Turca de Oncologia Médica e da Sociedade Europeia de Oncologia Médica
• Utiliza o perfilamento genômico abrangente para planos de tratamento personalizados
• Ativo em pesquisa clínica e terapias médicas experimentais

O Dr. Alemdar é especialista em oncologia médica com ampla formação na Universidade Akdeniz – líder em pesquisa de câncer.

• Certificado em oncologia médica desde 2018
• Atua no Medical Park Antalya Hospital Complex
• Mais de 15 anos de experiência em medicina interna e oncologia
• Formado na Universidade Akdeniz – o principal centro de pesquisa de câncer da Turquia

O Dr. Ozden é especializado em oncologia médica, com mais de 20 anos de experiência em medicina interna e oncologia.

• Concluiu a subespecialidade em oncologia médica na Faculdade de Medicina da Universidade de Kocaeli
• Exerceu medicina interna em vários hospitais na Turquia
• Formou-se na Faculdade de Medicina Cerrahpaşa da Universidade de Istambul

O Professor Associado Atakan Topcu é especializado em imunoterapia e terapias direcionadas para tumores sólidos no Hospital Distrital Medipol Acibadem.

• Publicou mais de 50 artigos científicos em oncologia
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Especialista em oncologia geriátrica e desnutrição relacionada ao câncer
• Formação de fellowship em oncologia médica obtida na Universidade Bezmialem Vakıf

Professor de Oncologia Médica com mais de 20 anos de experiência, especializado em tratamentos avançados de câncer no İstinye University Liv Hospital Topkapı.

• Formação de *Fellowship* em Oncologia Médica na Universidade Trakya
• Professor Associado e, posteriormente, Professor Titular na Faculdade de Medicina da Universidade Trakya
• Membro da Associação Turca de Oncologia Médica

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.